This article applies dose math to the verified JointBrex Supplement Facts panel. The label discloses all eight ingredients with per-amount figures, which is a transparency positive — it means every ingredient can be compared directly to published research. What that comparison reveals is a formula where the two most-studied compounds (glucosamine and chondroitin) arrive at sub-research-threshold doses, and five of the eight ingredients appear at 16.7 mg each — an amount below what any efficacy research on those compounds has used. The complete label data and how each dose lines up against peer-reviewed research is documented below.
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. This article is for informational and educational purposes only and does not constitute medical advice. Research citations reference studies on specific ingredients, not on JointBrex as a finished product.
The Verified JointBrex Supplement Facts Panel
Serving size: 2 vegetable capsules. Servings per container: 30. The Tutela Medical editorial team verified the following per-serving amounts from the official JointBrex Supplement Facts panel: Glucosamine Sulfate 1,000 mg; Boswellia Extract (Boswellia serrata, resin) 133.3 mg; Chondroitin Sulfate 100 mg; Turmeric (Curcuma longa, root) 100 mg; Quercetin (Sophora japonica, bud) 16.7 mg; Methionine 16.7 mg; MSM (Methylsulfonylmethane) 16.7 mg; Bromelain (Ananas comosus, stem) 16.7 mg. No proprietary blend is used — all ingredient amounts are individually disclosed. Other ingredients: Cellulose (Vegetable Capsule), Rice Flour. Allergen: Contains crustacean shellfish (crayfish).
Ingredient 1: Glucosamine Sulfate — 1,000 mg
What JointBrex provides: 1,000 mg per serving.
What research has used: 1,500 mg per day is the dose that the joint health evidence base has most consistently studied. A 2025 systematic review in Nutrients covering 146 studies found this to be the standard daily dose across efficacy trials, with over 90 percent of those studies reporting positive outcomes. The review found the combination of 1,500 mg glucosamine and 1,200 mg chondroitin was the most common regimen. Separately, studies on the structural effects of glucosamine on joint space narrowing — showing a 50 percent reduction in osteoarthritis-related surgery over a 5-year follow-up — used a prescription-grade crystalline glucosamine sulfate formulation at 1,500 mg per day.
Dose math result: JointBrex provides 1,000 mg — 33 percent below the 1,500 mg research threshold. This is the primary dose math finding for this formula.
Ingredient 2: Boswellia Extract — 133.3 mg
What JointBrex provides: 133.3 mg of Boswellia serrata resin extract. Standardization percentage not disclosed on label.
What research has used: Boswellia studies have used varying doses depending on standardization. A 2024 randomized controlled trial published in Frontiers in Pharmacology used a Boswellia serrata extract standardized to 30 percent AKBA (Boswellin Super) and found measurable reductions in knee joint discomfort markers (TNF-alpha, hs-CRP, IL-6) within five days. The 133.3 mg dose in JointBrex falls within ranges studied in some boswellia trials, but the absence of standardization disclosure means the actual AKBA content cannot be calculated.
Dose math result: Partially assessable. The 133.3 mg dose is within studied ranges. The missing standardization percentage prevents confirmation that the AKBA content matches what research has used. Boswellia efficacy depends heavily on formulation quality and AKBA concentration — a limitation worth noting when evaluating unstandardized boswellia products.
Ingredient 3: Chondroitin Sulfate — 100 mg
What JointBrex provides: 100 mg per serving.
What research has used: 800 to 1,200 mg per day. Major trials, including the GAIT trial published in the New England Journal of Medicine, used 1,200 mg of chondroitin sulfate per day alongside glucosamine. A 2024 meta-analysis in Inflammopharmacology covering 25 randomized controlled trials evaluating chondroitin sulfate found beneficial effects on pain and function — consistently at doses of 800 to 1,200 mg per day.
Dose math result: JointBrex provides 100 mg — approximately 8 to 12 percent of the research-supported range. This is the largest proportional dose gap in the formula. The inclusion of chondroitin is a formula-list positive, but the dose cannot be compared to what published research has studied.
Ingredient 4: Turmeric Root — 100 mg
What JointBrex provides: 100 mg of Turmeric (Curcuma longa, root) — root powder, not standardized extract.
What research has used: Research on curcumin for inflammation-related joint support has used standardized curcumin extracts (typically 95 percent curcuminoids) at 500 to 1,000 mg per day. Turmeric root powder contains approximately 2 to 5 percent curcuminoids by weight — meaning 100 mg of root powder delivers approximately 2 to 5 mg of curcumin equivalents. Bioavailability of curcumin from root powder is also lower than from formulated extracts without additional enhancement (piperine, phospholipid complexes, nanoparticle delivery).
Dose math result: 100 mg of turmeric root powder yields approximately 2 to 5 mg of curcumin. Research on curcumin has used 500 to 1,000 mg of standardized extract per day. For a deeper understanding of this distinction, see our glucosamine and chondroitin research guide.
Ingredient 5: Quercetin — 16.7 mg
What JointBrex provides: 16.7 mg of Quercetin from Sophora japonica bud.
What research has used: Quercetin research on anti-inflammatory and joint-adjacent applications has used 500 to 1,000 mg per day. At 16.7 mg, JointBrex provides approximately 1.7 to 3.3 percent of the studied dose range. Quercetin is a flavonoid with antioxidant properties that appear at higher concentrations in dietary sources (onions, apples, capers). Its presence in JointBrex at 16.7 mg does not align with any published human trial on joint-related outcomes.
Ingredient 6: Methionine — 16.7 mg
What JointBrex provides: 16.7 mg of Methionine, an essential amino acid involved in sulfur metabolism and connective tissue support.
What research has used: S-adenosylmethionine (SAMe) — a metabolite of methionine — has been studied for joint support at doses of 400 to 1,200 mg per day. Methionine itself as a direct supplement for joint applications has less of a direct evidence base at any dose. At 16.7 mg, no meaningful comparison to published research is possible.
Ingredient 7: MSM (Methylsulfonylmethane) — 16.7 mg
What JointBrex provides: 16.7 mg per serving.
What research has used: MSM studies for joint comfort have used 1,500 to 3,000 mg per day over 12 to 26 weeks. A frequently cited clinical study used 3,000 mg per day and found reductions in pain and physical impairment in knee osteoarthritis patients. At 16.7 mg, JointBrex provides less than 1 percent of the lowest dose used in any published MSM efficacy study.
Dose math result: Sub-therapeutic by a wide margin. MSM is present as an ingredient but the dose does not allow comparison to the research base.
Ingredient 8: Bromelain — 16.7 mg
What JointBrex provides: 16.7 mg of Bromelain from Ananas comosus (pineapple) stem.
What research has used: Bromelain research on anti-inflammatory applications has used doses of 200 to 2,000 mg per day depending on the indication. Studies in joint-adjacent contexts have used 400 to 1,000 mg. At 16.7 mg, JointBrex provides 1.7 to 8.4 percent of the dose range studied.
What the Transparency Analysis Shows
JointBrex does not use a proprietary blend — all ingredient amounts are individually disclosed on the Supplement Facts panel. This is a meaningful transparency positive that allows the dose math above to be run at all. Many competing products obscure ingredient amounts behind proprietary blend language, making comparison impossible. JointBrex earns credit for label transparency. The dose math analysis documents that transparency and its implications: the formula includes the right categories of ingredients for a joint support product, but the two most-studied compounds (glucosamine and chondroitin) arrive below published research thresholds, and five of eight ingredients arrive at 16.7 mg each.
For context on what the research actually shows for these ingredients at standard doses, see our glucosamine and chondroitin research guide. For the full product review including pricing, refund terms, and marketing claim verification, see our JointBrex review. For safety and interaction information before starting JointBrex, see our JointBrex side effects guide.
Frequently Asked Questions
Does JointBrex have enough glucosamine?
JointBrex provides 1,000 mg of Glucosamine Sulfate per serving. Published research has most consistently used 1,500 mg per day. JointBrex delivers 500 mg — one-third — below the research threshold.
How much chondroitin is in JointBrex?
JointBrex contains 100 mg of Chondroitin Sulfate per serving. Clinical research has used 800 to 1,200 mg per day. At 100 mg, JointBrex delivers approximately 8 to 12 percent of the dose used in those studies.
Is the MSM dose in JointBrex effective?
JointBrex contains 16.7 mg of MSM per serving. Research on MSM has used 1,500 to 3,000 mg per day. The 16.7 mg dose is approximately 1 percent of the lowest research dose studied and cannot be independently assessed for efficacy at this amount.
What type of turmeric is in JointBrex?
The label specifies Turmeric (Curcuma longa, root) — root powder, not standardized curcumin extract. At 100 mg of root powder, the curcumin content is approximately 2 to 5 mg. Research used standardized extracts at 500 to 1,000 mg per day.
Does JointBrex have a proprietary blend?
No. JointBrex discloses all per-ingredient amounts individually — a transparency positive that allows the dose math in this article to be performed.
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. This article is for informational and educational purposes only and does not constitute medical advice. The Tutela Medical editorial team independently verified the Supplement Facts panel from official product materials prior to publication.